DATABASE-RESEARCH | GROUP OF CLINICAL PATIENT RESEARCH | ||||||
E. ROOSNEK | Head of group CV | Research subject | Members of the group |
Links about the group
Prof. Eddy ROOSNEK HUG/Spécialités de Médecine Service d'Hématologie Rue Gabrielle-Perret-Gentil 4 1211 Genève 14 Eddy.Roosnek@hcuge.ch Tel.: + 41 22 372 94 13 Fax: 022 372 98 55 Comments Pages updated the 17.11.2015 |
Reseach's subject
|
Group's publications
|
Research's domains
?(en)
?(en)
Group's publications Synovial tissues concentrate secreted APRIL. ARTHRITIS RESEARCH & THERAPY 2009 vol. 11(5) pp. 144-144 GABAY C, KRENN V, BOSSHARD C, SEEMAYER CA, CHIZZOLINI C, HUARD B Tumors that look for their springtime in APRIL. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2009 vol. 72(2) pp. 91-97 ROOSNEK E, BURJANADZE M, DIETRICH PY, MATTHES T, PASSWEG J, HUARD B In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development. HISTOLOGY AND HISTOPATHOLOGY 2009 vol. 24(8) pp. 1061-1066 BURJANADZE M, MATTHES T, MCKEE T, PASSWEG J, HUARD B Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature". JOURNAL OF IMMUNOLOGY 2009 vol. 182(9) pp. 5159-5159 BELNOUE E, MATTHES T, SIEGRIST CA, HUARD B Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction TRENDS IN IMMUNOLOGY 2009 vol. 30(12) pp. 569-573 CONTASSOT E, PREYNAT-SEAUVE O, FRENCH L, HUARD B APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. BLOOD 2008 vol. 111(5) pp. 2755-2764 BELNOUE E, PIHLGREN BOSCH MARIA, MC GAHA T, TOUGNE C, ROCHAT AF, BOSSEN C, SCHNEIDER P, HUARD B, LAMBERT PH, SIEGRIST CA Heparan sulfate proteoglycans, Fc receptors, and DC suppression. BLOOD 2008 vol. 112(3) pp. 915-916 ROOSNEK E, SCHNEIDER P, HUARD B Human NK cells can control CMV infection in the absence of T cells. BLOOD 2008 vol. 112(3) pp. 914-915 KUIJPERS TW, BAARS PA, DANTIN C, VAN DEN BURG M, VAN LIER RA, ROOSNEK E Quality of life and social integration after allogeneic hematopoietic SCT. BONE MARROW TRANSPLANTATION 2008 vol. 42(12) pp. 819-827 BIERI S, ROOSNEK E, HELG C, VERHOLEN F, ROBERT D, CHAPUIS B, PASSWEG JAKOB, MIRALBELL R, CHALANDON Y Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells. CANCER RESEARCH 2008 vol. 68(20) pp. 8410-8418 SCHULER P, CONTASSOT E, IRLA M, HUGUES S, PREYNAT-SEAUVE O, BEERMANN F, DONDA A, FRENCH LE, HUARD B Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. EUROPEAN JOURNAL OF CANCER 2008 vol. 44(15) pp. 2097-2100 MHAWECH-FAUCEGLIA P, ALLAL ABDELKARIM, ODUNSI K, ANDREWS C, HERRMANN FR, HUARD B Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases. EXPERIMENTAL HEMATOLOGY 2008 vol. 36(5) pp. 533-534 WENT P, TZANKOV A, SCHWALLER J, PASSWEG JAKOB, ROOSNEK E, HUARD B APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. JOURNAL OF CLINICAL INVESTIGATION 2008 vol. 118(8) pp. 2887-2895 HUARD B AND AL Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells. JOURNAL OF IMMUNOLOGY 2008 vol. 180(7) pp. 4550-4560 VAN STIJN A, ROWSHANI AT, YONG SL, BAAS F, ROOSNEK E, TEN BERGE IJ, VAN LIER RA Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. SEMINARS IN IMMUNOPATHOLOGY 2008 vol. 30(4) pp. 425-437 STOREK J, GEDDES M, KHAN F, HUARD B, HELG C, CHALANDON Y, PASSWEG JAKOB, ROOSNEK E Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis ARTHRITIS AND RHEUMATISM -- 2007 vol. 56(10) pp. 3456-3467 PAREL YANN, AURRAND-LIONS MICHEL, SCHEJA AGNETA, DAYER JEAN-MICHEL, ROOSNEK EDDY, CHIZZOLINI CARLO Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness BLOOD 2007 vol. 109(1) pp. 331-338 SCHWALLER J, SCHNEIDER P, MHAWECH-FAUCEGLIA P, MCKEE T, MYIT S, MATTHES T, TSCHOPP J, DONZE O, LE GAL FA, HUARD B Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process CANCER RESEARCH 2007 vol. 67 pp. 5009-5016 PREYNAT-SEAUVE O, CONTASSOT E, SCHULER P, PIGUET V, FRENCH LE, HUARD B A new subset of human naive CD8(+) T cells defined by low expression of IL-7R alpha JOURNAL OF IMMUNOLOGY 2007 vol. 179 pp. 221-228 ALVES NL, VAN LEEUWEN EM, REMMERSWAAL EBM, VRISEKOOP N, TESSELAAR K, ROOSNEK E, TEN BERGE IJM, VAN LIER RAW Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease LEUKEMIA 2007 vol. 21(6) pp. 1324-1327 SCHWALLER J, WENT P, MATTHES T, DIRNHOFER S, DONZE O, MHAWECH-FAUCEGLIA P, MYIT S, HUARD B Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells MELANOMA RESEARCH 2007 vol. 17 pp. 169-176 PREYNAT-SEAUVE O, CONTASSOT E, SCHULER P, FRENCH LE, HUARD B HLA and KIR polymorphisms affect NK-cell anti-tumor activity TRENDS IN IMMUNOLOGY 2007 vol. 28 pp. 437-441 PASSWEG JR, HUARD B, TIERCY JM, ROOSNEK E Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 2006 vol. 12 pp. 102-110 CHALANDON Y, ROOSNEK E, MERMILLOD B, WAELCHLI L, HELG C, CHAPUIS B Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications BLOOD 2006 vol. 07(1) pp. 389-396 CHALANDON Y. ET AL. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland BONE MARROW TRANSPLANTATION 2006 vol. 37 pp. 909-916 CHALANDON Y, TIERCY JM, SCHANZ U, GUNGOR T, SEGER R, HALTER J, HELG C, CHAPUIS B, GRATWOHL A, TICHELLI A, DE FAVERI GN, ROOSNEK E, PASSWEG J Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection JOURNAL OF IMMUNOLOGY 2006 vol. 176 pp. 61-67 PREYNAT-SEAUVE O, SCHULER P, CONTASSOT E, BEERMANN F, HUARD B, FRENCH LE The source of APRIL up-regulation in human solid tumor lesions JOURNAL OF LEUKOCYTE BIOLOGY 2006 vol. 80 pp. 697-704 MHAWECH-FAUCEGLIA P, KAYA G, SAUTER G, MCKEE T, DONZE O, SCHWALLER J, HUARD B A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95. JOURNAL OF MOLECULAR MEDICINE 2006 vol. 84(9) pp. 785-797 ASSOHOU-LUTY C, GERSPACH J, SIEGMUND D, MÜLLER N, HUARD B, TIEGS G, PFIZENMAIER K, WAJANT H Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation PEDIATRICS 2006 vol. 117 pp. 1049-1056 SCHMID JMP, JUNGE SA, HOSSLE JP, SCHNEIDER EM, ROOSNEK E, SEGER RA, GUNGOR T Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantation TRANSPLANTATION 2006 vol. 81(9) pp. 1261-1267 BETTENS FLORENCE ET AL. Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sézary syndrome: circumvention by hexameric soluble CD40L BLOOD 2005 vol. 105(1) pp. 219-225 FRENCH LE, HUARD B, WYSOCKA M, SHANE R, CONTASSOT E, ARRIGHI JF, PIGUET V, CALDERARA S, ROOK AH Identification of proteoglycans as the APRIL-specific binding partners JOURNAL OF EXPERIMENTAL MEDICINE 2005 vol. 201 pp. 1375-1383 INGOLD K ET AL. Immunité cellulaire: les leçons de la transplantation de moelle osseuse allogénique (TMO) MEDECINE ET HYGIENE : JOURNAL SUISSE D'INFORMATIONS MEDICALES 2002 vol. 60 pp. 395-399 VILLARD J, CHAPUIS B, HELG C, ROOSNEK E Research's domains |